The NCCP have developed a number of guidance documents that are available below and in the HSE COVID-19 Clinical Guidance and Evidence Repository
Patient information on COVID-19
Patient information on COVID-19
|
Link
|
| NCCP Covid-19 Advice for People with Cancer |
Link |
Individual tumour site
Individual tumour site
|
Link
|
|
Prostate
NCCP guidance for Medical Professionals on the management of patients with Prostate Cancer in response to the current novel coronavirus (COVID-19) outbreak
|
Link |
|
Skin
NCCP advice for Medical Professionals on the Management of patients with Suspected or Diagnosed Malignant Melanoma or Non-Melanoma Skin Cancer in response to the current novel coronavirus (COVID-19) pandemic
|
Link |
Psycho-oncology
Psycho-oncology
|
Link
|
| Advice to inform safe re-opening of Cancer Support Centres |
Link |
Radiation Oncology
Radiation Oncology
|
Link
|
| NCCP patient pathway for attendance for radiation oncology during the COVID-19 pandemic |
Link |
| NCCP advice on the management of patients undergoing radiation oncology treatment, in response to the current novel coronavirus (COVID-19) outbreak |
Link |
| NCCP advice on radiation therapy capacity escalation plan in response to the current COVID 19 pandemic |
Link |
| NCCP guidance on the use of PPE by medical professionals when managing patients requiring radiotherapy in response to the current novel coronavirus (COVID-19) outbreak |
Link |
| NCCP advice for medical professionals on acceptable dose fractionation during the novel coronavirus (COVID-19) pandemic |
Link |
| Guidance on the Management of Treatment Gaps and Interruptions in Radical Fractionated Radiotherapy Arising from the COVID 19 Pandemic |
Link |
| Breast cancer: NCCP guidance for Medical Professionals on the management of patients undergoing Breast Cancer Radiotherapy in response to the current novel coronavirus (COVID-19) outbreak |
Link |
| Prostate cancer: NCCP advice for Medical Professionals on the management of patients undergoing Prostate Cancer Radiotherapy in response to the current novel coronavirus (COVID-19) outbreak |
Link |
| Thyroid cancer: NCCP advice for medical professionals on the management of Thyroid Cancer and Overactive Thyroid Disease in response to the current novel coronavirus (COVID-19) pandemic |
Link |
| Head and Neck cancers: NCCP guidance for Medical Professionals on the management of patients with head and neck cancer undergoing radiotherapy in response to the current COVID-19 pandemic |
Link |
| CNS cancer: NCCP advice for medical professionals on the treatment of patients with CNS tumours with radiotherapy in response to the COVID-19 pandemic |
Link |
| Lung cancer: NCCP advice for medical professionals on the management of patients undergoing Lung Cancer Radiotherapy in response to the current novel coronavirus (COVID-19) pandemic |
Link |
Rapid Access Clinics
Rapid Access Clinics
|
Link
|
|
NCCP Communication to GPs on Rapid Access Cancer Clinics in light of the current Covid-19 pandemic
|
Link
|
|
Breast
NCCP advice for Medical Professionals on the management of patients referred to the Symptomatic Breast Clinic in response to the current novel coronavirus (COVID-19) pandemic
|
Link
|
|
NCCP advice for Medical Professionals on minimising COVID19 risk in the Symptomatic Breast Disease Clinics
|
Link
|
|
COVID-19 Capacity Response Plan for Symptomatic Breast Disease (SBD) Clinics
|
Link
|
|
Prostate
NCCP guidance for Medical Professionals on the management of patients referred to the Rapid Access Prostate Clinics in response to the current novel coronavirus (COVID-19) pandemic
|
Link |
|
Lung
NCCP advice for Medical Professionals on the management of patients referred to the Rapid Access Lung Clinics in response to the current novel coronavirus (COVID-19) pandemic
|
Link |
Surgery
Surgery
|
Link
|
| NCCP patient pathway for admission for cancer surgery during the COVID-19 pandemic |
Link |
| NCCP advice for medical professionals on surgical oncology during the COVID-19 pandemic |
Link |
| NCCP guidance for Medical Professionals for testing COVID19 in asymptomatic patients undergoing elective cancer surgery in response to the current novel coronavirus pandemic |
Link |
| Rapid review of literature on a perioperative COVID-19 infection in cancer patients undergoing surgery |
Link |
Systemic Anti-Cancer Therapy
Systemic Anti-Cancer Therapy
|
Link
|
|
NCCP advice for Medical Professionals on the management of patients undergoing Systemic Anti-Cancer Therapy (chemotherapy) in response to the current coronavirus (COVID-19) outbreak
|
Link |
Testing
Testing
|
Link
|
| COVID-19 testing may be requested for asymptomatic patients prior to certain scheduled treatments. It is not a ‘rule-out’ test and will be used alongside advice to patients on reducing their likelihood of exposure in the two weeks prior to attendance and clinical review for signs and symptoms of disease. The below document outlines the process of requesting a test. This includes an option of having the swab taken by the National Ambulance Service, in which case the laboratory testing is still carried out by your usual hospital. |
|
| NCCP guidance for Medical Professionals for testing COVID19 in asymptomatic patients undergoing elective cancer surgery in response to the current novel coronavirus pandemic |
Link |
| NCCP patient pathway for admission for cancer surgery during the COVID-19 pandemic |
Link |
| NCCP patient pathway for attendance for SACT on an haematology/oncology day ward during the COVID-19 pandemic |
Link |
| NCCP patient pathway for admission to an haematology/oncology ward during the COVID-19 pandemic |
Link |
Updated: 10/02/2022
